Kyoto Drug Discovery & Development Co.

PharmaceuticalsSeries AOsaka-shi, Japankyoto-drug.com

Latest round

Series A

Last raised

Jun 2016

Total raised

$3.5M

Investors

5

About Kyoto Drug Discovery & Development Co.

, Ltd., Ltd. is engaged in the research and development of therapies for retinal disorders. Founded in 2015 in Osaka-shi, Japan, the company has executed a total of 4 deals, with its most recent deal occurring on July 31, 2019., Ltd. specializes in the development of innovative therapeutic agents aimed at treating retinal disorders, including central retinal artery occlusion, retinitis pigmentosa, and glaucoma. The company’s core offerings are designed to address significant unmet medical needs in ophthalmology, targeting the underlying mechanisms of these diseases to improve patient outcomes. The primary end users of these treatments include healthcare providers, such as ophthalmologists and clinics, as well as patients suffering from these debilitating conditions., Ltd. generates revenue primarily through partnerships with healthcare providers and research institutions, as well as potential future collaborations with pharmaceutical companies for the commercialization of their therapeutic products. The transaction structure may involve direct sales to hospitals and clinics or agreements that allow for the distribution of their treatments through established pharmaceutical networks. Revenue generation is likely to be derived from a combination of upfront payments, royalties, and milestone payments tied to the successful development and commercialization of their therapies., Ltd. The company is focused on expanding its market reach into North America and Europe by 2025, with ongoing efforts to advance its research and development activities.

Who invested in Kyoto Drug Discovery & Development Co.

5 investors across 2 rounds

See all investors in Kyoto Drug Discovery & Development Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jun 30, 2016

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    May 19, 2016

    Amount

    $3.5M

    Investors

    Locked

Questions about Kyoto Drug Discovery & Development Co.

Who invested in Kyoto Drug Discovery & Development Co.?

Kyoto Drug Discovery & Development Co. has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Kyoto Drug Discovery & Development Co. raised?

Kyoto Drug Discovery & Development Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Kyoto Drug Discovery & Development Co. last raise money?

Kyoto Drug Discovery & Development Co.'s most recent round on record is a Series A, in Jun 2016.

What does Kyoto Drug Discovery & Development Co. do?

Kyoto Drug Discovery & Development Co. is a pharmaceuticals company.

Where is Kyoto Drug Discovery & Development Co. headquartered?

Kyoto Drug Discovery & Development Co. is headquartered in Osaka-shi, Japan.

Which VCs invest in companies like Kyoto Drug Discovery & Development Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Kyoto Drug Discovery & Development Co.'s stage. Their profiles are linked below.

Raising like Kyoto Drug Discovery & Development Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.